TAG:
lab executive
Lawyer Argues: UroCor Charges Are a Concern
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: Criminal charges in the case against three ex-UroCor executives will likely alter existing compliance practices that affect how a lab offers price discounts to physicians and the way a lab uses “waiver of charges” in situations where it is an out-of-network provider. Atto…
FL Medicaid Lab Bid Gets Slammed By Foes
By Robert Michel | From the Volume XI No. 6 – April 26, 2004 Issue
CEO SUMMARY: Florida laboratories were caught by surprise last month when state Medicaid officials announced a 28-day process to award one lab with the state’s non-hospital Medicaid testing. To fight this RFP, a growing coalition of laboratories, lab industry trade groups, and the Flori…
Price Discount Practices May Prove Troublesome
By Robert Michel | From the Volume XI No. 3 – February 23, 2004 Issue
CEO SUMMARY: Some laboratories continue to offer deeply-discounted prices to the nation’s largest managed care plans as a way to maintain provider status and keep market share. In one case, these deep discounts surprised a long-time lab executive, who decided to share the information, a…
“Free Testing” Strategy Stirs the Pot in Tenn.
By Robert Michel | From the Volume X No. 16 – December 1, 2003 Issue
CEO SUMMARY: In Tennessee, the state’s Medicaid HMO plan has been at odds with Quest Diagnostics Incorporated, which is using the “free testing” strategy to expand its share of the market. In recent months, TennCare Select has taken active steps to insure its physicians understand tha…
“May 5, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
There are rumors coming from the West Coast that government laboratory regulators are targeting at least one laboratory company for some significant violations. Because allegations of compliance violations by the government can severely damage a lab company’s reputation, there is a tight lid on infor…
“April 14, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 5 – April 14, 2003 Issue
Lab executives and pathologists concerned about closed panel HMOs should closely study a recent Supreme Court decision. On April 2, the court issued a ruling that supports a state’s right to enact “any willing provider” laws. Kentucky had passed two laws requiring health plans to accept all out…
Medicare “Bill Back” Policies Vary By Lab
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
CEO SUMMARY: When it comes to the subject of Medicare medical necessity, the classic “compliance conundrum” is again at work. Laboratories with conservative, strict compliance policies believe they are at a disadvantage at retaining physician-clients and winning new accounts when comp…
Integrity Remains a Valued Business Asset
By R. Lewis Dark | From the Volume X No. 3 – March 3, 2003 Issue
LATELY I SEEM TO BE LIVING UP TO MY ROLE as the “crusty curmudgeon.” The opinions and commentaries I contributed to these pages in recent issues of THE DARK REPORT triggered a considerable number of letters and feedback from our clients and regular readers. In particular, my observations about …
Quest Finally Owns Unilab, New Market Cycle To Begin
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
PERSISTENCE FINALLY PAID OFF for Quest Diagnostics Incorporated. On February 26, it took ownership of Unilab Corporation, capping almost 11 months of effort. In completing this acquisition, Quest Diagnostics completes the two blood brothers’ acquisition sweep of m…
Jamaica Med Techs, Kaiser Permanente, Cytyc, Myriad Genetics, Bayer, CLMA
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
MEDICAL TECHNOLOGISTS IN JAMAICA STAGE WALK-OUT IN JANUARY LABORATORY TECHS ARE NOT KNOWN to be a radical component of the labor movement. But that doesn’t seem to be the case in Jamaica, where more than 80 of that country’s medical technologists walked off their jobs twice in January in…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized